{"id":"W3018517995","doi":"10.1136/annrheumdis-2020-217139","title":"EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors","year":2020,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":276,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Cilag; Pharmacyclics; Chugai Pharmaceutical; LEO Pharma; Regeneron Pharmaceuticals; Gilead Sciences; European League Against Rheumatism; Celgene; Biogen; Sanofi; Amgen; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Immunotherapy; Cancer immunotherapy; Adverse effect; Cancer; Ipilimumab; Immunology; Intensive care medicine; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002755313,0.0002171152,0.0005188387,0.00005805009,0.00008935483,0.000008446963,0.0002353271,0.00003309079,0.0001362025],"category_scores_gemma":[0.000135629,0.0001177206,0.0003144144,0.0003856992,0.0001473909,0.0000587559,0.0001002591,0.00005488806,0.000002807189],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002541106,"about_ca_system_score_gemma":0.00008107536,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003364919,"about_ca_topic_score_gemma":0.00001256861,"domain_scores_codex":[0.9984333,0.00006341454,0.0006823891,0.0002263242,0.0003675935,0.0002269652],"domain_scores_gemma":[0.9986851,0.0002322612,0.0003343479,0.0004551664,0.0001392226,0.0001539215],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.06035922,0.003939012,0.1005979,0.02748377,0.05367739,0.00004529924,0.03848535,0.003230158,0.006250898,0.0009196384,0.05275427,0.6522571],"study_design_scores_gemma":[0.01274142,0.002207977,0.9101811,0.0254861,0.00189813,0.00001778693,0.005443817,0.0006440292,0.03702307,0.0007472089,0.002963939,0.0006453776],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9396714,0.01028695,0.000126812,0.04635802,0.0001275335,0.00327872,0.0001039879,0.00002920759,0.00001736683],"genre_scores_gemma":[0.9883037,0.006871313,0.0003183545,0.003728695,0.00000995585,0.0006587031,0.000004174593,0.00004609034,0.0000589768],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8095832,"threshold_uncertainty_score":0.4800508,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04184898885750181,"score_gpt":0.3192135867304184,"score_spread":0.2773645978729166,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}